Free Trial

Aravive (ARAV) Short Interest Ratio & Short Volume

Aravive logo
$0.04 0.00 (0.00%)
As of 05/2/2025

Aravive Short Interest Data

Aravive (ARAV) has a short interest of 1.33 million shares. This marks a -5.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 0 shares to cover all short positions.

Current Short Interest
1,330,000 shares
Previous Short Interest
1,400,000 shares
Change Vs. Previous Month
-5.00%
Dollar Volume Sold Short
$160,930.00
Short Interest Ratio
0.3 Days to Cover
Last Record Date
January 15, 2024
Outstanding Shares
73,563,000 shares
Percentage of Shares Shorted
1.81%
Today's Trading Volume
0 shares
Average Trading Volume
0 shares
Today's Volume Vs. Average
NaN
Short Selling Aravive?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Aravive and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ARAV Short Interest Over Time

ARAV Days to Cover Over Time

ARAV Percentage of Float Shorted Over Time

Aravive Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/15/20241,330,000 shares $160,930.00 -5.0%N/A0.3 $0.12
12/31/20231,400,000 shares $173,180.00 -43.3%N/A0.3 $0.12
12/15/20232,470,000 shares $342,095.00 +20.5%N/A0.4 $0.14
11/30/20232,050,000 shares $299,300.00 -42.7%N/A0.3 $0.15
11/15/20233,580,000 shares $481,510.00 -37.1%N/A0.4 $0.13
10/31/20235,690,000 shares $743,114.00 -18.3%N/A0.6 $0.13
10/15/20236,960,000 shares $1.03 million +27.5%N/A0.6 $0.15
9/30/20235,460,000 shares $720,720.00 -25.2%N/A0.7 $0.13
9/15/20237,300,000 shares $1.17 million +63.0%N/A1.1 $0.16
8/31/20234,480,000 shares $667,520.00 +21.4%N/A0.7 $0.15
8/15/20233,690,000 shares $723,609.00 -51.5%N/A1.3 $0.20
7/31/20237,610,000 shares $10.65 million +12.9%N/A3.9 $1.40
7/15/20236,740,000 shares $10.85 million +4.3%N/A23.6 $1.61
6/30/20236,460,000 shares $8.14 million +3.5%N/A24.2 $1.26
6/15/20236,240,000 shares $9.80 million +22.6%N/A24.1 $1.57
5/31/20235,090,000 shares $8.65 million +11.9%N/A17.1 $1.70
5/15/20234,550,000 shares $7.28 million +5.6%N/A14.8 $1.60
4/30/20234,310,000 shares $6.12 million +7.8%N/A14.1 $1.42
4/15/20234,000,000 shares $6.72 million +3.9%N/A13.6 $1.68
3/31/20233,850,000 shares $7.70 million +77.4%N/A13.7 $2.00
3/15/20232,170,000 shares $3.49 million +16.0%N/A8.4 $1.61
2/28/20231,870,000 shares $3.57 million +58.5%N/A10.1 $1.91
2/15/20231,180,000 shares $2.49 million +10.3%N/A7.3 $2.11
1/31/20231,070,000 shares $1.79 million +4.9%N/A7.4 $1.67
1/15/20231,020,000 shares $1.83 million +23.3%N/A1.6 $1.79
12/30/2022827,100 shares $1.09 million +3.3%N/A1.3 $1.32
12/15/2022800,400 shares $1.32 million +44.0%N/A1.3 $1.65
11/30/2022555,700 shares $744,638.00 +4.9%N/A0.9 $1.34
11/15/2022530,000 shares $832,100.00 +76.9%N/A0.8 $1.57
10/31/2022299,600 shares $392,476.00 +52.1%N/A0.5 $1.31
10/15/2022197,000 shares $182,904.65 -17.3%1.1%1.4 $0.93
9/30/2022238,200 shares $194,657.04 -22.5%1.4%1.9 $0.82
9/15/2022307,200 shares $316,416.00 +142.7%1.8%2.5 $1.03
8/31/2022126,600 shares $85,113.18 -0.9%0.8%1.1 $0.67
8/15/2022127,700 shares $107,306.31 +15.5%0.8%1.2 $0.84
7/31/2022110,600 shares $96,553.80 -17.1%0.7%1.2 $0.87
7/15/2022133,400 shares $119,019.48 -5.5%0.9%1.4 $0.89
6/30/2022141,200 shares $139,491.48 +19.4%0.9%1.5 $0.99
6/15/2022118,300 shares $128,947.00 +6.2%0.8%1.3 $1.09
5/31/2022111,400 shares $145,934.00 -1.5%0.7%1.4 $1.31
Altucher: Turn $900 into $108,000 in just 12 months? (Ad)

We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.

If I’m right about this (like I was before) a modest $900 investment…
5/15/2022113,100 shares $124,410.00 -8.1%0.7%1.8 $1.10
4/30/2022123,100 shares $168,647.00 +11.5%1.2%2.1 $1.37
4/15/2022110,400 shares $184,368.00 -1.9%1.1%1.9 $1.67
3/31/2022112,500 shares $217,125.00 -82.6%1.1%1.9 $1.93
3/15/2022646,600 shares $1.26 million -1.5%5.0%8.7 $1.95
2/28/2022656,400 shares $1.44 million -1.9%5.1%8.2 $2.20
2/15/2022668,900 shares $1.44 million +1.4%5.2%7.3 $2.15
1/31/2022660,000 shares $1.43 million +2.0%5.2%6.5 $2.16
1/15/2022647,300 shares $1.57 million +3.5%5.1%6.6 $2.43
12/31/2021625,700 shares $1.37 million +89.0%4.9%6.5 $2.19
12/15/2021331,000 shares $880,460.00 +29.9%2.6%3.6 $2.66
11/30/2021254,900 shares $820,778.00 +59.3%2.0%2.8 $3.22
11/15/2021160,000 shares $633,600.00 -14.8%1.3%2 $3.96
10/29/2021187,800 shares $666,690.00 -24.3%1.5%2.3 $3.55
10/15/2021248,100 shares $913,008.00 -43.0%2.0%2.9 $3.68
9/30/2021435,200 shares $1.62 million -25.4%3.5%3.8 $3.72
9/15/2021583,600 shares $2.28 million +6.8%4.7%1.1 $3.91
8/31/2021546,500 shares $2.36 million -18.6%4.4%1 $4.32
8/13/2021671,700 shares $2.73 million -16.0%5.4%1.2 $4.07
7/30/2021799,500 shares $3.32 million +2.8%6.4%1.4 $4.15
7/15/2021777,900 shares $3.49 million -48.8%6.7%1.3 $4.49
6/30/20211,520,000 shares $9.09 million +10.1%13.2%2.6 $5.98
6/15/20211,380,000 shares $7.36 million -7.4%11.9%9 $5.33
5/28/20211,490,000 shares $7.64 million +0.7%12.9%7.4 $5.13
5/14/20211,480,000 shares $7.06 million +13.0%13.2%6.9 $4.77
4/30/20211,310,000 shares $7.35 million +75.6%11.7%5.2 $5.61
4/15/2021746,000 shares $4.08 million +27.7%6.9%3.3 $5.47
3/31/2021584,400 shares $3.58 million +14.7%N/A2.6 $6.12
3/15/2021509,500 shares $3.68 million +14.6%4.5%2.4 $7.22
2/26/2021444,800 shares $3.16 million -20.6%4.7%2.3 $7.11
2/12/2021560,400 shares $3.84 million -3.7%6.0%3.1 $6.85
1/29/2021581,900 shares $3.21 million -6.8%5.7%3.7 $5.51
1/15/2021624,100 shares $3.56 million -4.3%6.1%4.2 $5.71
12/31/2020652,400 shares $3.90 million -4.8%6.4%4.4 $5.98
12/15/2020685,200 shares $4.35 million -3.7%6.7%4.6 $6.35
11/30/2020711,500 shares $4.01 million -20.9%6.9%4.7 $5.64
11/15/2020899,400 shares $4.98 million -2.8%8.8%6.8 $5.54
10/30/2020925,500 shares $4.43 million -5.0%9.5%6.2 $4.79
10/15/2020974,300 shares $4.92 million -2.5%10.0%4.6 $5.05
9/30/2020999,600 shares $4.70 million -12.3%10.3%4.4 $4.70
9/15/20201,140,000 shares $6.83 million -1.7%11.8%4.3 $5.99
8/31/20201,160,000 shares $6.61 million +10.5%12.0%4.5 $5.70
8/14/20201,050,000 shares $6.76 million +9.6%10.9%4.2 $6.44
7/31/2020958,000 shares $5.64 million -6.1%10.6%4.3 $5.89
7/15/20201,020,000 shares $11.39 million +15.5%11.4%5.6 $11.17
6/30/2020883,400 shares $10.28 million +234.1%9.8%4.4 $11.64
6/15/2020264,400 shares $3.66 million -21.8%3.0%1.7 $13.84
5/29/2020338,000 shares $4.14 million -0.5%3.8%2 $12.24
5/15/2020339,600 shares $4.31 million -43.9%4.0%2 $12.69

ARAV Short Interest - Frequently Asked Questions

What is Aravive's current short interest?

Short interest is the volume of Aravive shares that have been sold short but have not yet been closed out or covered. As of January 15th, traders have sold 1,330,000 shares of ARAV short. Learn More on Aravive's current short interest.

Is Aravive's short interest increasing or decreasing?

Aravive saw a decrease in short interest during the month of January. As of January 15th, there was short interest totaling 1,330,000 shares, a decrease of 5.0% from the previous total of 1,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Aravive's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aravive: Lakeshore Biopharma Co., Ltd. (0.32%), Athira Pharma, Inc. (2.45%), Flora Growth Corp. (2.06%), BioCardia, Inc. (1.08%), Portage Biotech Inc. (80.67%), Hoth Therapeutics, Inc. (1.70%), Eterna Therapeutics Inc. (0.90%), Incannex Healthcare Inc. (0.91%), BioXcel Therapeutics, Inc. (1.63%), BioLineRx Ltd. (5.87%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.10 billion), General Motors ($3.90 billion), Charter Communications, Inc. ($3.31 billion), Occidental Petroleum Co. ($2.91 billion), Tractor Supply ($2.75 billion), Moderna, Inc. ($2.44 billion), Coinbase Global, Inc. ($2.10 billion), United Rentals, Inc. ($2.09 billion), Royal Caribbean Cruises Ltd. ($2.03 billion), and Rivian Automotive, Inc. ($1.89 billion). View all of the most shorted stocks.

What does it mean to sell short Aravive stock?

Short selling ARAV is an investing strategy that aims to generate trading profit from Aravive as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Aravive?

A short squeeze for Aravive occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARAV, which in turn drives the price of the stock up even further.

How often is Aravive's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARAV, twice per month. The most recent reporting period available is January, 15 2024.




This page (NASDAQ:ARAV) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners